We are live on ! Find out more
VIVS

VivoSim Labs
VIVS

117 hedge funds and large institutions have $67M invested in VivoSim Labs in 2017 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 36 increasing their positions, 28 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 28

22% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 9

2% more funds holding

Funds holding: 115 → 117 (+2)

0.01% more ownership

Funds ownership: 0.1% → 0.1% (+0.01%)

13% less capital invested

Capital invested by funds: $76.7M → $67M (-$9.66M)

65% less call options, than puts

Call options by funds: $343K | Put options by funds: $989K

Holders
117
Holders Change
+2
Holders Change %
+1.74%
% of All Funds
2.92%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
36
Reduced
28
Closed
9
Calls
$343K
Puts
$989K
Net Calls
-$646K
Net Calls Change
+$338K

Top Buyers

1
AIM
ARK Investment Management
Florida
+$2.32M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$617K
3
Citadel Advisors
Citadel Advisors
Florida
+$576K
4
State Street
State Street
Massachusetts
+$423K
5
BlackRock
BlackRock
New York
+$297K

Top Sellers

1
Morgan Stanley
Morgan Stanley
New York
-$465K
2
QIM
Quantitative Investment Management
Virginia
-$396K
3
VKH
Virtu KCG Holdings
New York
-$326K
4
QI
Quotient Investors
New York
-$285K
5
Tudor Investment Corp
Tudor Investment Corp
Connecticut
-$238K
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$20.1M +$297K +441 +1%
Vanguard Group
2
Vanguard Group
Pennsylvania
$11.8M +$617K +918 +5%
State Street
3
State Street
Massachusetts
$4.46M +$423K +629 +10%
AIM
4
ARK Investment Management
Florida
$3.8M +$2.32M +3,453 +134%
UBS Group
5
UBS Group
Switzerland
$3.35M -$41K -61 -1%
Northern Trust
6
Northern Trust
Illinois
$3.16M +$68.6K +102 +2%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$2.57M +$63.9K +95 +2%
Bank of New York Mellon
8
Bank of New York Mellon
New York
$1.13M -$102K -152 -8%
Charles Schwab
9
Charles Schwab
California
$1.02M +$7.4K +11 +0.7%
Fidelity International
10
Fidelity International
Bermuda
$982K – – –
EIM
11
Essex Investment Management
Massachusetts
$948K +$149K +222 +17%
Morgan Stanley
12
Morgan Stanley
New York
$882K -$465K -692 -33%
TCIM
13
TIAA CREF Investment Management
New York
$763K +$96.1K +143 +13%
AFG
14
American Financial Group
Ohio
$662K – – –
Citadel Advisors
15
Citadel Advisors
Florida
$646K +$576K +857 +516%
TA
16
Teachers Advisors
New York
$619K +$192K +285 +41%
GIP
17
Granite Investment Partners
California
$576K -$29.6K -44 -5%
LFR
18
Lehman Financial Resources
Pennsylvania
$472K +$89.4K +133 +22%
California State Teachers Retirement System (CalSTRS)
19
California State Teachers Retirement System (CalSTRS)
California
$459K -$44.4K -66 -8%
Swiss National Bank
20
Swiss National Bank
Switzerland
$429K – – –
Wells Fargo
21
Wells Fargo
California
$412K -$672 -1 -0.2%
Deutsche Bank
22
Deutsche Bank
Germany
$379K +$256K +381 +169%
Susquehanna International Group
23
Susquehanna International Group
Pennsylvania
$372K +$80.7K +120 +26%
JMPWA
24
JP Morgan Private Wealth Advisors
California
$302K +$10.8K +16 +3%
RhumbLine Advisers
25
RhumbLine Advisers
Massachusetts
$290K +$12.8K +19 +4%
1
2 3 4 5

VIVS Hedge Fund Activity: Q2 2017 in Review

117 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in VivoSim Labs (VIVS) for Q2 2017, worth a combined $67M — down 13% from $76.7M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new VIVS positions and 9 closed out — a net gain of 2 holders — while 36 added to existing stakes and 28 trimmed.

The largest buyer was ARK Investment Management, adding an estimated $2.32M. The largest seller was Morgan Stanley, cutting an estimated $465K.

  • 117 institutional investors held VivoSim Labs (VIVS) as of Q2 2017, up from 115 in Q1 2017.
  • Funds reported $67M of VivoSim Labs stock for Q2 2017, down 13% quarter-over-quarter.
  • 11 funds opened new VivoSim Labs positions in Q2 2017 and 9 closed out, a net change of +2 holders.
  • The largest VivoSim Labs buyer in Q2 2017 was ARK Investment Management, an estimated $2.32M added.
  • The largest VivoSim Labs seller in Q2 2017 was Morgan Stanley, an estimated $465K sold.

Based on aggregated 13F filings for Q2 2017.